http://www.pharmaceutical-technology.com/news/fda-grants-gsk-first-ever-approval-for-rsv-vaccine/
0
0
30 words
0
Comments
Amidst steep competition, GSK’s Arexvy becomes the first approved RSV vaccine worldwide for preventing RSV in older adults.
You are the first to view
Create an account or login to join the discussion